Allogene Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2020
Total Assets: $1.23B
Liabilities Breakdown FY2020
Total Liabilities: $148.2M
Asset Breakdown
Total Assets: $1.23B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $183.4M | 14.9% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $118.8M | 9.7% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $925.6M | 75.4% |
Liabilities Breakdown
Total Liabilities: $148.2M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $10.4M | 7.0% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $137.8M | 93.0% |